Zydus Lifesciences continues to be under intense scrutiny from the FDA, which hit the Indian drugmaker’s production facility ...

The letter, received on August 30, 2024, identifies concerns related to current good manufacturing practices (cGMP), which ...

Zydus Lifesciences Ltd. received a warning letter issued by the United States Food and Drug Administration with respect to ...

Global brokerage firm Jefferies has said that the recent correction in Zydus Lifesciences presents a buying opportunity.

Elara Capital sees Zydus Lifesciences' stock correction as a buying opportunity, upgrading it to 'buy' with a target of ₹1497 ...

The warning letter, received on August 30, 2024, will not affect product supply to the US or the company’s financial ...

(PTI) -Zydus Lifesciences on Saturday said it has inked a pact with Perfect Day Inc to acquire 50 per cent stake in Sterling ...

The warning letter summarises violations regarding the current good manufacturing practice regulations, the company said in a ...

Despite the acquisition effort, analysts await details on the joint venture's renewed strategy and planned investments to ...

Zydus Lifesciences acquires 50% stake in Sterling Biotech, entering fermentation-based protein business for global markets.

Zydus Lifesciences entered a joint venture with Perfect Day by acquiring a 50% stake in Sterling Biotech. The collaboration ...

Zydus Lifesciences Ltd obtained final approval from the USFDA to market its Scopolamine transdermal system, designed to ...